IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BERTON GIACHETTI, PIER PAOLO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 552
NA - Nord America 466
EU - Europa 447
SA - Sud America 61
AF - Africa 16
OC - Oceania 2
Totale 1.544
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 440
SG - Singapore 178
IT - Italia 166
CN - Cina 143
DE - Germania 96
VN - Vietnam 64
HK - Hong Kong 49
BD - Bangladesh 43
BR - Brasile 42
SE - Svezia 36
FR - Francia 35
RU - Federazione Russa 27
NL - Olanda 26
IN - India 23
CA - Canada 14
FI - Finlandia 14
AR - Argentina 12
GB - Regno Unito 10
CI - Costa d'Avorio 8
KR - Corea 8
JP - Giappone 7
MX - Messico 7
PH - Filippine 7
SA - Arabia Saudita 7
TR - Turchia 7
AT - Austria 5
ID - Indonesia 5
CZ - Repubblica Ceca 4
ES - Italia 4
PL - Polonia 4
ZA - Sudafrica 4
IE - Irlanda 3
IR - Iran 3
VE - Venezuela 3
AU - Australia 2
BE - Belgio 2
BY - Bielorussia 2
CH - Svizzera 2
CL - Cile 2
NO - Norvegia 2
PK - Pakistan 2
RO - Romania 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UA - Ucraina 2
UZ - Uzbekistan 2
AL - Albania 1
BB - Barbados 1
BG - Bulgaria 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MY - Malesia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SC - Seychelles 1
Totale 1.544
Salva come PNG Salva come JPEG
Città #
Dallas 87
Singapore 83
Frankfurt am Main 81
Ashburn 72
Hefei 53
San Jose 43
Milan 39
Santa Clara 38
Hong Kong 37
Council Bluffs 26
Hanoi 22
Boardman 21
Ho Chi Minh City 18
Los Angeles 18
Rome 16
Beijing 14
New York 11
Bengaluru 10
Lauterbourg 10
Abidjan 8
Seoul 8
Florence 7
Mexico City 6
Naples 6
Tokyo 6
Brooklyn 5
Buenos Aires 5
Buffalo 5
Da Nang 5
Düsseldorf 5
Guangzhou 5
Munich 5
Riyadh 5
Vienna 5
Chandler 4
Denver 4
Helsinki 4
Lappeenranta 4
Moscow 4
Mumbai 4
Opera 4
Paris 4
Toronto 4
Turku 4
Atlanta 3
Belo Horizonte 3
Dublin 3
Genoa 3
Hyderabad 3
Istanbul 3
Miano 3
Modena 3
Montesilvano Marina 3
Montreal 3
Prague 3
Shanghai 3
Shenzhen 3
Warsaw 3
Amsterdam 2
Bari 2
Bucharest 2
Cagliari 2
Cape Town 2
Cebu City 2
Changsha 2
Columbus 2
Curitiba 2
Foshan 2
Fuquay-Varina 2
Go Vap 2
Greensboro 2
Haiphong 2
Jeddah 2
Johannesburg 2
Minsk 2
Morrow 2
Orem 2
Philadelphia 2
Pompei 2
Princeton 2
Reggio Emilia 2
Santiago 2
Sasso Marconi 2
St Louis 2
Sunapee 2
Suzhou 2
Tashkent 2
Teresópolis 2
Turin 2
Washington 2
Wuhan 2
Épalinges 2
Alexandria 1
Ancona 1
Angicos 1
Ankara 1
Argenteuil 1
Avaré 1
Bahía Blanca 1
Barcelona 1
Totale 943
Salva come PNG Salva come JPEG
Nome #
Advancing treatment choices: CDK4/6 inhibitor switching in HR+/HER2- metastatic breast cancer 215
Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer 197
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapy 168
Prognostic impact of tumor-infiltrating lymphocytes in HER2+ metastatic breast cancer receiving first-line treatment 156
Radioligand Therapy in Metastatic Breast Cancer: Harnessing Precision Oncology 151
Fed or fasted state for oral therapies in breast cancer treatment? A comprehensive review of clinical practice recommendations 150
Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection 144
Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study 134
Immune-Related Adverse Event Likelihood Score Identifies “Pure” IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population 125
PARP Inhibitors for Breast Cancer Treatment 94
Extendeond Endocrine Therapy and Survival for Breast Cancer Subtypes in Premenopausal Patients 21
Safety of mRNA-COVID-19 Vaccines in Patients With Thoracic Cancers 10
Pyrotinib in combination with first-line trastuzumab and docetaxel for patients with HER2-positive metastatic breast cancer: a new therapeutic option? 9
Genomic tests for risk stratification in patients with early human epidermal growth factor receptor 2-positive breast cancer 8
Harnessing Vaccines in the Treatment of Solid Tumors: Advances, Challenges, and Future Directions 7
Impact of breast cancer on sexuality and psycho-physical wellbeing: Survey analysis 6
Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study 4
Pembrolizumab and oral metronomic cyclophosphamide in patients with chest wall breast cancer (PERICLES): an immune-biomarker analysis of tumor infiltrating lymphocytes (TILs) and programmed cell death ligand protein 1 (PD-L1) 3
null 3
Current controversies in the use of Oncotype DX in early breast cancer 1
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting 1
Abstract HER2-02: HER2-02 HER2-Low Status is Associated with Worse Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Patients Treated With First-Line Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy 1
Totale 1.608
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.369
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.369
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202228 0 0 1 7 2 2 2 2 6 2 2 2
2022/202322 5 3 2 0 1 4 1 1 1 2 2 0
2023/202422 2 1 0 6 2 0 1 3 0 1 1 5
2024/2025235 6 14 6 8 7 2 0 24 13 35 43 77
2025/20261.241 118 129 196 116 72 50 149 56 86 50 114 105
2026/202760 60 0 0 0 0 0 0 0 0 0 0 0
Totale 1.608